By 2024 Latin America Molecular Diagnostics Market Size to Grow at Valuation of USD 950 Mn

Graphical Research has reported the addition of the “Molecular Diagnostics Market: Latin America Industry Analysis and Opportunity Assessment 2019 - 2024" report to their offering.

India - August 14, 2019 /MarketersMedia/ —

Growing awareness about early disease diagnosis and prevention has stimulated demand for molecular diagnostics in detection of cancer and infectious disease at early stage. Molecular diagnostics has become an integral part of disease management owing to its wide applications in drug regimen selection, therapeutic monitoring, patient stratification and detection of predisposition to disease. High accuracy level coupled with reliability and efficacy will further surge the demand for molecular diagnostics thereby boosting Latin America molecular diagnostics business growth.

Request for a sample of this report @ https://www.graphicalresearch.com/request/1174/sample

According to the Graphical Research new growth forecast report titled Latin America Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In Situ Hybridization, Chips & Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification), Industry Analysis Report, Country Outlook (Brazil, Mexico, Argentina, Colombia, Chile, Peru), 2018 – 2024”, estimated to exceed USD 950 million by 2024.

Furthermore, technological advancement in molecular diagnostics will serve to be positive impact rendering factor in business growth. Availability of small handheld portable POCT devices used by healthcare professionals or patients will escalate the demand for point of care diagnostics. Rising incidence of lifestyle diseases such as diabetes, growing investment in R&D to develop cost effective and user-friendly POCT devices and increasing focus of industry players on new product development will stimulate molecular diagnostics market growth. However, lack of uniform regulatory framework may impede Latin America molecular diagnostics industry growth over the coming years.

Infectious disease segment accounted for more than USD 220 million in 2017 and is projected to show similar growth over the coming years. Prevalence of infectious diseases such as flu, tuberculosis, meningitis, STD, HIV, hepatitis C, hepatitis B, dengue and others is increasing in recent years. Rising awareness about early disease diagnosis and timely treatment will spur the demand for molecular diagnostics. Availability of rapid molecular tests delivering results in few hours will increase its adoption in detection of infectious disease and will fuel segmental growth during forthcoming years.

Make an Inquiry for purchasing this Report @ https://www.graphicalresearch.com/request/1174/inquiry-before-buying

PCR segment held significant revenue share in 2017 and is expected to witness around 8.5% CAGR over the forecast period. Technological advancements in PCR including target specific PCR allowing amplification and simultaneous detection of pathogen DNA will drive business growth. Increasing usage of PCR in medical industry and diagnostic laboratories will spur segment revenue. Moreover, application of PCR in molecular diagnostics for monitoring of chronic osteomyelitis ensures accurate results. Thus aforementioned factors will foster PCR segmental growth over the analysis timeframe.

Brazil molecular diagnostics market is estimated to witness more than USD 385 million by 2024. Growing demand for robust, rapid and reproducible diagnosis of infectious diseases for better control of mortality and morbidity will positively impact Brazil molecular diagnostics business growth over the forecast period. Focus of industry players on development and distribution of affordable devices resulting in increased use of molecular diagnosis tests will propel business size. Increasing demand for cost-effective diagnosis and advanced technologies for better patient outcomes will accelerate industry growth.

Browse Table of Contents @ https://www.graphicalresearch.com/table-of-content/1174/latin-america-molecular-diagnostics-market

Few prominent players operating in Latin America molecular diagnostics market include Abbott, Agilent, Analytik Jena, Becton, Dickinson & Company, Biocartis, BioFire Diagnostics, BioMérieux, Bio-Rad Laboratories, Danaher and Genomic Health. Industry players are undertaking numerous initiatives to gain higher market share and strengthen market position. For instance, in May 2017, company launched Alere Malaria Ag P.f assay for asymptomatic malaria infection. This strategy enabled company to enhance its existing product portfolio and capitalize on market opportunities.

Segments we cover:

Latin America Molecular Diagnostics Market, By Application

Infectious disease
Flu
RSV virus
Tuberculosis
Meningitis
HIV market
Hepatitis C
Hepatitis B
HPV
STD
Chlamydia
Gonorrhea
Others
Dengue
H. Pylori
TORCH
Others
Blood screening
Genetic testing
Oncology testing

Latin America Molecular Diagnostics Market, By Technology

PCR
In situ hybridization
Chips & microarrays
Mass spectrometry
Sequencing
Isothermal amplification
Others

Browse key industry insights from this Report @ https://www.graphicalresearch.com/industry-insights/1174/latin-america-molecular-diagnostics-market

Contact Info:
Name: Parikhit B.
Email: Send Email
Organization: Graphical Research
Website: https://www.graphicalresearch.com/industry-insights/1174/latin-america-molecular-diagnostics-market

Source URL: https://marketersmedia.com/by-2024-latin-america-molecular-diagnostics-market-size-to-grow-at-valuation-of-usd-950-mn/88908156

Source: MarketersMedia

Release ID: 88908156

More News From Daily Sports Club

Belgium forward Lukaku joins Inter Milan from Man United

Aug 22, 2019

MILAN — Inter Milan completed the signing of Belgium forward Romelu Lukaku from Manchester United on Thursday. Lukaku put pen to paper on a five-year deal with Inter, joining his younger brother in the Italian league. Jordan Lukaku plays for Serie A rival Lazio. No financial details were given, but Italian media reported that Inter paid United around 65 million euros ($73 million) plus 13 million euros ($15 million) in bonuses for the 26-year-old Lukaku. "Inter were the only club I wanted, because Inter is 'Not For Everyone.' I'm here to bring the Nerazzurri back to the top," Lukaku said....

Ronaldo returns to training at Juventus

Aug 22, 2019

TURIN, Italy — Cristiano Ronaldo has arrived back at Juventus for his first day of pre-season training. The 34-year-old Ronaldo was greeted by more than 100 fans Saturday on his arrival for standard medical tests. The fans shouted his name as well as chanting for him to win the Champions League for them as a smiling Ronaldo signed autographs and posed for selfies. Ronaldo will train for the first time under new Juventus coach Maurizio Sarri later Saturday. Ronaldo was signed from Real Madrid just over a year ago in the hope that the five-time World Player of the Year...

Teunissen wins Tour opening stage, Thomas crashes at end

Aug 22, 2019

BRUSSELS — Mike Teunissen claimed the first yellow jersey of this year's Tour de France with a sprint victory in Saturday's opening stage, which was marked by defending champion Geraint Thomas' crash in the finale. Thomas' Ineos team said he fell in the final meters but "feels fine." Another top contender, Jakob Fuglsang, also hit the tarmac about 20 kilometers (12 miles) from the finish in a separate crash. The 26-year-old Teunissen, who became the first Dutch rider to wear the yellow jersey since Erik Breukink 30 years ago, edged former world champion Peter Sagan and Caleb Ewan on the...

Cavendish's Tour de France omission creates internal rift

Aug 22, 2019

BRUSSELS — Mark Cavendish's omission from the Tour de France is creating a rift within his Dimension Data team. Team principal Doug Ryder insisted on Saturday at the start of the Tour's opening stage he made the right decision by leaving the 34-year-old sprinter at home, a move that left head of performance Rolf Aldag puzzled. Cavendish, who has 30 stage wins on the Tour, has not produced a single win this season while struggling to recover from the Epstein-Barr virus, but hoped he could get back in contention at cycling's marquee race. "Mark is a legend of the race....

Cycling's new generation ready to deliver at Tour de France

Aug 22, 2019

BRUSSELS — No matter who wins, this year's Tour de France will see a changing of the guard. And if the names of Wout Van Aert, Kasper Asgreen, Enric Mas or Caleb Ewan don't ring a bell now, they might soon be on everybody's lips. In the absence of many stalwart riders who have stamped their mark on cycling's marquee event in recent years, new faces will emerge this summer. There is a long list of top riders missing the Tour, which starts on Saturday from Brussels with a 194.5 kilometer (120.8-mile) stage through Flanders and back to the Belgian...

Search

About Us

From transfer news, tactical analysis to predictions, get only the best of the world of sports daily with Daily Sports Club.

Contact us: sales[at]dailysportsclub.com

Subscribe Now!